| Literature DB >> 132142 |
M Gandola, G Argenziano, C Barba, R Bassi, M Binazzi, G Landi, L Levi, D Randazzo, F Serri, A P Villano.
Abstract
A controlled non-blind multicenter trial was conducted in 211 acne patients to test the activity of topical retinoic acid against sulfur-resorcinol--salicylic acid and placebo. Uniform evaluation criteria were used. After 8 weeks' treatment in comparable groups of patients, retinoic acid proved to be superior to the standard and to the placebo. The difference was statistically significant. Side effects were present in a number of patients treated with the active substances and with the placebo (mainly erythema), but rarely was the treatment discontinued.Entities:
Mesh:
Substances:
Year: 1976 PMID: 132142 DOI: 10.1007/bf00558520
Source DB: PubMed Journal: Arch Dermatol Res Impact factor: 3.017